• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies

    Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics

    NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidisciplinary research questions, generate insights, and integrate that information back into their existing Oracle Health and Life Sciences applications. As a result, life sciences organizations can more accurately identify market needs, assess commercial viability, and optimize therapeutic launch strategies. This innovation is yet another step in Oracle's vision to bridge the gap between clinical research and clinical care.

    (PRNewsfoto/Oracle)

    "Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."

    Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.

    Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.

    This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.

    The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.

    For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Q&A

    New
    • What is the recent product launched by Oracle for life sciences?

      Oracle has launched the Oracle Analytics Intelligence for Life Sciences, an AI-powered platform designed to unite disparate data sets and accelerate insight generation for life sciences organizations.

    • What types of data sources does the Oracle Analytics Intelligence for Life Sciences utilize?

      The new platform integrates data from various sources, including electronic health records, insurance claims, and demographic records, to provide comprehensive insights on patient experiences and therapy effectiveness.

    • How does Oracle Analytics Intelligence for Life Sciences intend to impact therapeutic launch strategies?

      This platform aims to bridge the gap between clinical research and clinical care, allowing organizations to identify market needs, assess the commercial viability of treatments, and optimize therapeutic launch strategies.

    • What functionalities does the Oracle Analytics Intelligence platform offer to its users?

      The platform supports multidisciplinary research questions and continuously updates insights using real-world data to improve decision-making and patient care outcomes.

    • What is Oracle's broader vision with the introduction of the Analytics Intelligence for Life Sciences?

      The launch is part of Oracle's strategy to modernize clinical research and tightens the connection between research and actual patient care through advanced analytics and data integration.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    7/10/2025$270.00Neutral → Overweight
    Piper Sandler
    7/2/2025$235.00 → $245.00Outperform
    BMO Capital Markets
    6/30/2025$250.00Hold → Buy
    Stifel
    6/18/2025$220.00 → $250.00Buy
    Guggenheim
    6/13/2025$235.00Market Perform → Outperform
    BMO Capital Markets
    6/9/2025$175.00 → $200.00Market Perform
    BMO Capital Markets
    4/23/2025$130.00Overweight → Neutral
    Piper Sandler
    3/19/2025$167.00Equal-Weight
    Stephens
    More analyst ratings

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      7/9/25 4:39:51 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      3/21/25 8:43:30 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      2/14/25 4:41:16 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Oracle Database@AWS Now Generally Available

      Customers can now use Oracle Database@AWS in AWS Regions in Northern Virginia and Oregon, with planned expansion to 20 more  Enterprises including Fidelity Investments, Nationwide, and SAS are adopting Oracle Database@AWS to migrate and run Oracle Exadata Database Service and Oracle Autonomous Database on OCI within AWS  AUSTIN, Texas and SEATTLE, July 8, 2025 /PRNewswire/ -- Oracle and Amazon Web Services, Inc. (AWS) today announced the general availability of Oracle Database@AWS. Customers can now run Oracle Exadata Database Service and Oracle Autonomous Database on dedicated infrastructure on Oracle Cloud Infrastructure (OCI) within AWS. Oracle Database@AWS is available in the AWS U.S. Ea

      7/8/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform

      Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of pharmacovigilance services, the CRO is leveraging Argus to provide its clients with a powerful, AI-driven solution to help optimize their drug development programs and support patient safety and regulatory compliance. PrimeVigilance is part of the Ergomed Group whose mission is to deliver leading solutions that support its customers' clinical projects to speed t

      7/8/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Banks Can Speed Access to Capital with New Oracle Trade and Supply Chain Finance Cloud Services

      Automation and streamlined operations enable greater speed, transparency, and value-added services to corporate clients AUSTIN, Texas, June 30, 2025 /PRNewswire/ -- New Oracle Trade Finance and Supply Chain Finance cloud services are empowering banks to provide corporate and small- and medium-sized enterprise (SME) clients faster access to financing through streamlined trade processes. Oracle has introduced these new cloud services to unify operations and help manage the entire trade and supply chain finance lifecycles. The new trade finance service enables banks to streamline, automate, and manage trade finance operations across geographies and currencies, improving operational efficiency a

      6/30/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Oracle upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Oracle from Neutral to Overweight and set a new price target of $270.00

      7/10/25 8:27:04 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • BMO Capital Markets reiterated coverage on Oracle with a new price target

      BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $245.00 from $235.00 previously

      7/2/25 8:04:33 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle upgraded by Stifel with a new price target

      Stifel upgraded Oracle from Hold to Buy and set a new price target of $250.00

      6/30/25 7:56:35 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Oracle Corporation

      25-NSE - ORACLE CORP (0001341439) (Subject)

      7/10/25 9:34:55 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 8-K filed by Oracle Corporation

      8-K - ORACLE CORP (0001341439) (Filer)

      6/30/25 8:30:26 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Oracle Corporation

      144 - ORACLE CORP (0001341439) (Subject)

      6/27/25 4:13:03 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chairman Ellison Lawrence Joseph exercised 6,000,000 shares at a strike of $51.13, increasing direct ownership by 0.52% to 1,151,732,353 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      7/11/25 4:38:47 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      7/9/25 4:39:51 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • EVP, Chief Accounting Officer Smith Maria sold $2,329,897 worth of shares (10,000 units at $232.99), decreasing direct ownership by 20% to 40,807 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      7/8/25 4:44:10 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

      Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

      10/30/24 9:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Meharry Medical College and Oracle Collaborate to Advance Healthcare Access, Innovation, and Education

      Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th

      10/30/24 8:55:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/9/24 4:33:37 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/23 4:31:02 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/22 8:28:11 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Financials

    Live finance-specific insights

    See more
    • Oracle Announces Fiscal 2025 Fourth Quarter and Fiscal Full Year Financial Results

      Q4 Remaining Performance Obligations up 41% to $138 billionQ4 GAAP Earnings per Share $1.19, non-GAAP Earnings per Share $1.70Q4 Total Revenue $15.9 billion, up 11%Q4 Cloud Revenue (IaaS plus SaaS) $6.7 billion, up 27%Q4 Cloud Infrastructure (IaaS) Revenue $3.0 billion, up 52%Q4 Cloud Application (SaaS) Revenue $3.7 billion, up 12%Q4 Fusion Cloud ERP (SaaS) Revenue $1.0 billion, up 22%Q4 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 18%FY 2025 Total Revenue $57.4 billion, up 8%AUSTIN, Texas, June 11, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced fiscal 2025 Q4 and full-year 2025 results. Total quarterly revenues were up 11% year-over-year in USD and constant curren

      6/11/25 4:05:00 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle Sets the Date for its Fourth Quarter Fiscal Year 2025 Earnings Announcement

      Earnings Results to be released on June 11, 2025, After the Close of the Market AUSTIN, June 3, 2025 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter and fiscal year 2025 results will be released on Wednesday, June 11th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

      6/3/25 4:00:00 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Izzi Improves Customer Experience and Revenue Growth with Oracle

      Mexican telecommunications operator reduces bill run times by 70% and achieves greater agility with Oracle Digital Business Experience on Oracle Cloud Infrastructure MEXICO CITY and AUSTIN, Texas, May 1, 2025 /PRNewswire/ -- Izzi, a subsidiary of Televisa Group, is modernizing its business support systems (BSS) in the cloud to bolster customer experience. By upgrading to the latest version of Oracle Communications Digital Business Experience running on Oracle Cloud Infrastructure (OCI), Izzi has reduced billing times by 70% and invoicing times by 60%, allowing the company to receive payments faster and improve cash flow. Izzi embarked on its modernization and cloud migration journey with su

      5/1/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology